TW200716555A - Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents - Google Patents

Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents

Info

Publication number
TW200716555A
TW200716555A TW095113519A TW95113519A TW200716555A TW 200716555 A TW200716555 A TW 200716555A TW 095113519 A TW095113519 A TW 095113519A TW 95113519 A TW95113519 A TW 95113519A TW 200716555 A TW200716555 A TW 200716555A
Authority
TW
Taiwan
Prior art keywords
production
inflammatory agents
tetrahydronaphthalene derivatives
tetrahydronaphthalene
derivatives
Prior art date
Application number
TW095113519A
Other languages
English (en)
Chinese (zh)
Inventor
Stefan Baurle
Heike Schacke
Markus Berger
Anne Mengel
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of TW200716555A publication Critical patent/TW200716555A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
TW095113519A 2005-04-14 2006-04-14 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents TW200716555A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005017286A DE102005017286B3 (de) 2005-04-14 2005-04-14 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer

Publications (1)

Publication Number Publication Date
TW200716555A true TW200716555A (en) 2007-05-01

Family

ID=36955993

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095113519A TW200716555A (en) 2005-04-14 2006-04-14 Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents

Country Status (8)

Country Link
AR (1) AR056314A1 (fr)
DE (1) DE102005017286B3 (fr)
GT (1) GT200600153A (fr)
PA (1) PA8668901A1 (fr)
PE (1) PE20061313A1 (fr)
TW (1) TW200716555A (fr)
UY (1) UY29481A1 (fr)
WO (1) WO2006108714A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7662821B2 (en) 2003-10-08 2010-02-16 Bayer Schering Pharma Ag Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
US7638515B2 (en) 2003-10-08 2009-12-29 Bayer Schering Pharma Aktiengesellschaft Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
WO2005034939A1 (fr) 2003-10-08 2005-04-21 Schering Aktiengesellschaft Derives de tetrahydronaphtalene a substitution 1-amino-2-oxy, procedes pour leur production et leur utilisation en tant qu'anti-inflammatoires
US20080153859A1 (en) 2004-04-05 2008-06-26 Hartmut Rehwinkel Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
EP1834948A1 (fr) 2006-03-15 2007-09-19 Bayer Schering Pharma Aktiengesellschaft Derives de tetrahydronaphtalene , procedes pour leur production et leur utilisation en tant qu'anti-inflammatoires
EP1917963A1 (fr) * 2006-10-31 2008-05-07 Bayer Schering Pharma Aktiengesellschaft Imidazoles cycliques substitués par un groupe phényle, procédé pour leur préparation et leur utilisation comme des agents anti-inflammatoires

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03289659A (ja) * 1990-03-28 1991-12-19 Toshiba Corp 感光性組成物
EP0980393A1 (fr) * 1997-05-05 2000-02-23 First Chemical Corporation Photoamorceurs biradicaux
DE10038639A1 (de) * 2000-07-28 2002-02-21 Schering Ag Nichtsteroidale Entzündungshemmer
AU8022901A (en) * 2000-08-21 2002-03-04 Pacific Corp Novel thiourea derivatives and the pharmaceutical compositions containing the same
RU2331635C2 (ru) * 2002-05-08 2008-08-20 Байер ХельсКер АГ Производные гидрокси-тетрагидро-нафталенилмочевины
WO2003097586A1 (fr) * 2002-05-17 2003-11-27 Janssen Pharmaceutica N.V. Modulateurs de l'uree derives de l'aminotetraline du recepteur vanilloide vr1
AU2003273556A1 (en) * 2002-06-04 2003-12-19 Galderma Research & Development, S.N.C. Ligands that are inhibitors of the rar receptors
WO2005034939A1 (fr) * 2003-10-08 2005-04-21 Schering Aktiengesellschaft Derives de tetrahydronaphtalene a substitution 1-amino-2-oxy, procedes pour leur production et leur utilisation en tant qu'anti-inflammatoires

Also Published As

Publication number Publication date
WO2006108714A2 (fr) 2006-10-19
DE102005017286B3 (de) 2006-12-28
GT200600153A (es) 2007-03-19
UY29481A1 (es) 2006-10-31
PA8668901A1 (es) 2007-01-17
WO2006108714A3 (fr) 2007-01-04
AR056314A1 (es) 2007-10-03
PE20061313A1 (es) 2006-12-20

Similar Documents

Publication Publication Date Title
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
TW200722079A (en) Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
MX2007014172A (es) Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
CY1112495T1 (el) Κυτταροτοξικοι παραγοντες που περιλαμβανουν νεα παραγωγα τομαϋμυκινης
PL1891004T3 (pl) Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
TW200638930A (en) Acetylene derivatives
CY1109568T1 (el) Ενωσεις βενζο(d)ισοξαζολ-3-υλαμινης και η χρησιμοποιηση τους σαν προσδεματα υποδοχεα βανιλλοειδων
MX2009003382A (es) Derivados de sulfonamidas sustituidos.
MX339476B (es) Compuestos que incluyen un nucleo farmaceutico antiinflamatorio y sus metodos de uso.
UA83875C2 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
TW200740814A (en) Compounds
PT1877367E (pt) Derivados do acetileno
TW200700064A (en) Novel compounds
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
RS20060250A (en) 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, method for the production thereof, and their use as antiphlogistics
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
UA94603C2 (ru) Производные тетрагидронафталина, способ их получения и их применения в качестве ингибиторов воспаления
TN2010000219A1 (en) 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
MX2009000480A (es) Bencilaminas, un proceso para su produccion y su uso como agentes antiinflamatorios.
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
SI1745010T1 (sl) Substituirani cikloheksil-1,4-diaminski derivati
TW200716555A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
TW200738611A (en) 9-Chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
MX2007013872A (es) Procedimiento para la produccion de 4-bifenililazetidina-2-onas.